Breaking Headlines

Category archive

Health

Medical Ceramics Market is Expected to Reach $5,841 Million by 2022, Globally-Allied Market Research

in BREAKING NEWS/Business and Finance/Health/medical ceramics/medicine/organizations/Press Release by
Reading Time: 3 minutes

PORTLAND, Oregon and PUNE, India, March 15, 2017 /360WiseNews/ —

A new report published by Allied Market Research titled, Medical Ceramics Global Opportunity Analysis and Industry Forecast, 20142022“, projects that the global medical ceramics market was valued at $3,850 million in 2015, and is expected to reach $5,841 million by 2022, registering a CAGR of 6.2% from 2016 to 2022. Implants segment is expected to remain the highest revenue contributor throughout the forecast period. U.S. held the leading position in the global market in 2015, and is expected to maintain its lead throughout the study period.

 

Summary of the Medical Ceramics Market can be accessed on the website at:https://www.alliedmarketresearch.com/medical-ceramics-market

According to Eswara Prasad, Team Lead Chemical Research at Allied Market Research, Medical ceramics are widely preferred in dentistry due to their large compressive and load bearing capacity and similarity with dental materials such as enamel.

The upsurge in the demand for medical ceramics from medical device industry creates attractive opportunities for market growth. Properties of medical ceramics such as high compressive strength and biodegradability, which are necessary for bone implants are leading market growth. Medical ceramics minimize bone ingrowth, which is a key factor boosting its adoption in the market. Growth in applications of medical ceramics for inartificial total hip, knee, shoulder, elbow, wrist; bone plates, screws, wires; intramedullary nails; permanently implanted artificial limbs; spinal fusion; alveolar bone replacements, mandibular reconstruction; and tooth replacement implants has opened new growth avenues for medical ceramics market. Growth in ceramic implants market has also fueled the demand for medical ceramics as it can be framed to match the material properties of a natural bone.

The application of the medical ceramics in the implants segments holds highest share in 2015 and is expected to maintain its lead throughout the forecast period. The increase in use of ceramics as rigid materials to manufacture implants is due to absence of prosthetics, thus reducing the risk of bacterial growth. Zirconia and alumina are the most commonly used ceramic materials used to develop implants. Zirconia, a type of bio-inert ceramic is expected to be the fastest growing segment in the global medical ceramics market followed by piezo ceramics. Ceramics are preferred for orthopedic implants by manufacturers due to their high resistance and biochemical inertness. Alumina is the most commonly used ceramic utilized for manufacturing orthopedic implants. Keep Reading

Global Atopic Dermatitis Drugs Market 2017-2021

in BREAKING NEWS/dermatitis/disease/Health/medicine/public relations/research market by
Reading Time: 2 minutes

NEW YORK, March 7, 2017 /360WiseNews/ — Atopic Dermatitis Drugs

Atopic dermatitis is a common, chronic, relapsing, inflammatory disease that primarily affects young children. Atopy refers to an inherited tendency to produce IgE antibodies, whereas, dermatitis means inflammation of the skin. Atopic dermatitis is associated with asthma, inhalant allergies (hay fever), and chronic dermatitis. In this condition, the skin becomes extremely itchy and inflamed, which causes redness, cracking, weeping, swelling, vesicle formation, crushing, and scaling. Atopic dermatitis is very common worldwide, and its prevalence rate is increasing. The data estimates suggest that nearly 60% of the patients develop symptoms in the first year of life, and 88%-92% develop symptoms before the age of five.

Technavio’s analysts forecast the global atopic dermatitis drugs market to grow at a CAGR of 4.20% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global atopic dermatitis drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of atopic dermatitis drugs.

The market is divided into the following segments based on geography:
– Americas
– APAC
– EMEA

Technavio’s report, Global Atopic Dermatitis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Keep Reading

North Dallas Research Associates and Cardiac Center of Texas Begin Enrollment in TOBA II BTK Clinical Trial for New Peripheral Revascularization Treatment Option

in BREAKING NEWS/cardiac/Health/knee tack/medicine/Today In History by
Reading Time: 3 minutes

Dr. Khan Deployed the First Below the Knee Tack System in the South East Region and Only Second in the Country

MCKINNEY, Texas, March 2, 2017 /360WiseNews/ — North Dallas Research Associates and its private practice, Cardiac Center of Texas, announced today their participation in the Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) clinical trial. TOBA II BTK is a study that offers physicians a new option to treat patients suffering from advanced peripheral artery disease (PAD) or critical limb ischemia (CLI). Using the Tack Endovascular System®, the innovative technology is designed specifically to repair dissections following standard balloon angioplasty in the popliteal and tibial arteries with minimal stress to the vessels.

“We’re very excited to enroll the first patient in Texas to be treated in this groundbreaking clinical study,” said Dr. M. Akram Khan, Cardiologist at Cardiac Center of Texas. “TOBA II BTK provides the latest vascular technology for those in the Dallas area suffering from advanced PAD.”

PAD is a disease of the blood vessels in the legs and feet that occurs when arteries become narrow or clogged and don’t receive enough blood flow to meet the body’s needs. A recent analysis suggests more than 8 million Americans have peripheral artery disease, with 12-20% of individuals ages 65+ being affected. When left untreated, PAD can lead to critical limb ischemia (CLI), a more serious form of the disease. There are more than one million people in the United States living with CLI. CLI patients experience similar symptoms to PAD patients; however, CLI symptoms can significantly increase in severity from pain when resting, to open sores, to life-threatening conditions like gangrene, and can eventually require limb amputation in some patients. According to the U.S. Department of Health and Human Services, clogged arteries in the legs, just like clogged arteries in the heart, put individuals at risk for heart attack or stroke.

The Tack Endovascular System is equipped with self-sizing technology that allows one Tack implant to fit arteries ranging from 1.5mm to 4.5mm in diameter. This flexibility eliminates the need to precisely size the device to the arterial diameter, which is necessary with conventional stents. The device then allows physicians to “spot treat” the vessel only where dissections are present, rather than leave dissections untreated or covering them with large metal stents. This technique minimizes the amount of implanted metal and reduces vessel trauma and inflammation.

“Advanced PAD and CLI are large areas of fast-growing unmet need, both clinically and from a health economics perspective,” added Dr. Khan. “Patients with CLI suffer from debilitating symptoms and have few effective treatment options. It is important for the medical community to collaborate in this study to further the treatment options for patients with such advanced disease.”

Additional information regarding this trial can be found at clinicaltrials.gov by searching the term NCT02522884.

About the Tack Endovascular System and the TOBA II BTK Clinical Trial
For more information about the TOBA II BTK trial, please visit www.intactvascular.com

About North Dallas Research Associates and Cardiac Center of Texas
Established in 2003 by Dr. M. Akram Khan, NDRA has grown steadily for more than 10 years building expertise in clinical research operations. We are a team of professional and dedicated staff led by Dr. Khan, who manages and conducts a vast variety of clinical trials. Currently, the site has three principal investigators conducting clinical trials under various specialties. Keep Reading

Animal Dermatology Clinic Pasadena is home to a new treatment that could signal relief for pets

in Animals/BREAKING NEWS/Health/medicine/pets by
Reading Time: 2 minutes

PASADENA, Calif., March 2, 2017 /360WiseNews/ — Animal Dermatology Clinic (ADC) Pasadena is now offering a new treatment that speeds up the healing process for pets, with Hyperbaric Oxygen Therapy (HBOT). Introduced in human medicine as the primary treatment for decompression sickness after diving, hyperbaric oxygen therapy delivers a high oxygen concentration, combined with increased air pressure in the chamber, allowing oxygen to diffuse into the tissues to advance the healing process.

ADC Pasadena remains on the forefront of innovating its practice by currently being the only dermatology specialist in the world to offer this state-of-the-art equipment in-house. This new technology enhances ADC’s years of experience and advancements in clinical research which will further its impact on the future of veterinary dermatology. These contributions to the veterinary community will continue to demonstrate ADC’s commitment to excellence in patient care.

The use of hyperbaric oxygen therapy in veterinary medicine has been used to heal a variety of medical conditions through a noninvasive treatment that delivers 100-percent oxygen under pressure. It has been very effective for non-healing wounds, burns, deep tissue infections, bone infections, decubital ulcers, vasculitis, and post-surgical recovery. Keep Reading

Global Breast Cancer Therapeutics Market Analysis 2016-2022: Company Profiling Covering the Financials, Recent Activities and Future Strategies – Research and Markets

in Breast Cancer/global/Health/Press Release by
Reading Time: 2 minutes

DUBLIN, Mar 01, 2017 /360WiseNews/ —

Research and Markets has announced the addition of the “Global Breast Cancer Therapeutics Market Analysis 2016 – Forecast to 2022” report to their offering.

Research and Markets Logo

The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America).

Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

– Market Sizing estimations and forecasts for 6 years across the given market segments
– Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, )
– Strategic recommendations in key business segments based on the market estimations
– Regional and country level market analysis
– Competitive landscaping of major market players
– Company profiling covering the financials, recent activities and the future strategies

Key Topics Covered:

1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Breast Cancer Therapeutics Market by Clinical Study
5.1 Introduction
5.2 Phase I
5.3 Phase II
5.4 Phase III Drugs

6 Breast Cancer Therapeutics Market by Drug Class
6.1 Introduction
6.2 Mitotic Inhibitors
6.2.1 Ixempra (Ixabepilone)
6.2.2 Halaven (Eribulin)
6.2.3 Taxotere (Docetaxel)
6.3 Anti-metabolites
6.3.1 Gemzar (Gemcitabine)
6.4 Hormone Receptor
6.4.1 Zoladex
6.4.2 Faslodex
6.4.3 Fareston
6.5 Aromatase Inhibitors
6.5.1 Femara (Leterozole)
6.5.2 Arimidex (Anastrozole)
6.5.3 Aromasin (Exemestane)
6.5.4 Ibrance (Palbociclib)
6.5.5 Afinitor (Everolimus)
6.6 HER2 Inhibitors
6.6.1 Kadcyla (Ado-trastuzumab emtansine)
6.6.2 Tykerb (Lapatinib)
6.6.3 Perjeta (Pertuzumab)
6.6.4 Herceptin (Trastuzumab) Keep Reading

7 Innovative Petcare Products With Human Grade Designs

in BREAKING NEWS/Business and Finance/food/Health/pets by
Reading Time: 3 minutes

The line between products for humans and products for dogs & cats are blurring much to the delight of pet owners nationwide

ROCKVILLE, Md., March 1, 2017 /360WiseNews/ — American pet owners are spending more than ever on petcare products and services, to the tune of $80 billion in 2016, and when it comes to caring for pets, time is money. No surprise then that U.S. pet owners are willing to spend big on products that promise to save them time, according to market research publisher Packaged Facts in the report Durable Dog and Cat Petcare Products in the U.S.

Products designed to make petcare more efficient are all the rage, the ultimate being those able to lift the petcare burden altogether. From self-cleaning litter boxes to automated feeders and waterers to smart collars with Bluetooth monitoring capabilities, today’s petcare products are increasingly expected to also provide a service.  In proprietary surveys of U.S. pet owners conducted by Packaged Facts, “product will save time/make my life easier” is a top purchase motivator for automated products including litter boxes, feeders, waterers, toys, training devices, pet doors, and many other categories.

At least much as the needs of the pet, the needs of pet owners are shaping petcare marketing and R&D.  The same can be said for pet owners’ desires. Pretty much across the board of durable petcare categories—and especially for those intersecting with fashion or home décor—pet owners confess to factoring in purchase motivators including “prestige/fashion appeal” and “appearance/style.” In other words, in today’s market, the emotional needs and aspirations of pet owners are at least as important as that other ubiquitous purchase motivator,” my pet will love it.” As with everything else, when it comes to the pet products they buy, Americans want it all—high quality and good price, form and function, and goods that please pet and person.

Homing in on product innovation and consumer preferences, Durable Dog and Cat Petcare Products in the U.S. examines all of these trends, breaking out this $3.7 billion market into seven categories:

  • Toys, including cat scratchers and play furniture, where products are adopting human forms, interactive/training toys, self-entertaining toys, revamped plushes, natural/eco-friendly options, and high-tech features.
  • Beds, where durability, ease of cleaning, and comfort combine with trends including innovative designs (think raised edges and tenting), temperature control, portability/travel, fashion/humanization, and natural/eco-friendly.
  • Carriers, crates, and housing, a category in which travel friendliness cannot be overestimated, along with fashion and style, with many pet owners seeking out items that serve as a fashion accessory and/or complete their home décor.
  • Collars, harnesses, leashes (including training products), where pet owners’ interest in product quality and safety are driving the proliferation of items designed to protect pets and their people from injury while making walking ever more convenient and stylish.
  • Bowls, feeders, waterers (manual and automatic) including food storage, where new products are alleviating neck strain, improving digestion, and maximizing comfort and convenience while adding a stylish look to pet owners’ homes.
  • Apparel/fashion accessories, a category previously seasonal in nature is now offering year-round options including a lot more functional gear.
  • Litter boxes and accessories including scoops, mats, waste disposal systems, and litter additives, where performance and convenience are the watchwords and automation and more attractive designs are coming on strong.

About the Report

Durable Dog and Cat Petcare Products in the U.S.—a first edition report covers pet Toys; Beds; Carriers, Crates, & Housing; Collars, Leashes, & Harnesses; Bowls, Feeders, & Waterers; Apparel & Fashion Accessories; and Litter Boxes & Accessories. In the report, Packaged Facts quantifies the market as a whole as well as category by category, calculating historical compound annual growth rates for 2011 vs. 2016 and projected growth rates for 2016 vs. 2021. Through custom surveying in Packaged Facts’ own National Pet Owner Surveys, it cuts to the core of consumer preferences in each category by compiling responses to questions.

View additional information about Durable Dog and Cat Petcare Products in the U.S., including purchase options, the abstract, table of contents, and related reports at Packaged Facts’ website: http://www.packagedfacts.com/Durable-Dog-Cat-10522406/.    Keep Reading

Health Coalition Encouraged by Congressional and Administration Support of Medical Liability Reform

in BREAKING NEWS/Health/liability by
Reading Time: 1 minute

WASHINGTON, March 1, 2017 /360WiseNews/ — The Health Coalition on Liability and Access (HCLA) applauded Congress and the Administration for supporting passage of medical liability reform in the 115th Congress.

On Tuesday, Feb. 28, 2017, the House Judiciary Committee approved the Protecting Access to Care Act, a comprehensive medical liability reform bill introduced by Representative Steve King (R-IA).

The Protecting Access to Care Act, H.R. 1215, is modeled after proven reforms already in place in Texas, California, and many other states around the country that have had a positive effect on increasing patient access to care and keeping health care costs affordable for patients and physicians.

Later Tuesday evening, President Trump expressed his support for medical liability reforms in his address to a Joint Session of Congress.

“…We should implement legal reforms that protect patients and doctors from unnecessary costs that drive up the price of insurance,” President Trump stated.

“The HCLA is pleased that the House of Representatives and President Trump recognize the need for comprehensive federal medical liability reform, and have made a commitment to address this issue as a key priority in the 115th Congress,” said HCLA Chair Mike Stinson. “We will work to increase the momentum we achieved on Tuesday so that we may implement vital changes to our medical liability system to keep patient care safe, affordable and accessible.” Keep Reading

Represent Partners with Ice Cube to Raise Awareness and Funding for Autism Speaks

in autism/BREAKING NEWS/Entertainment/Health/HipHop/Partnership by
Reading Time: 2 minutes

Limited edition apparel campaign aims to make it a ‘good day’ for families affected by autism

LOS ANGELES, March 1, 2017 /360WiseNews/ — Represent, a social merchandising and marketing platform that enables influencers to create and sell custom apparel, today announced the launch of limited edition apparel campaign with Ice Cube to benefit Autism Speaks. The legendary rapper and actor, whose family has a loved one with autism personally selected the organization and worked with Represent on an exclusive t-shirt design inspired by his 1993 “It Was a Good Day” music video.

“I’m proud to support the great work that Autism Speaks does, a cause that is so important to me,” said Ice Cube. “My goal through this campaign is to not only help raise awareness but to also support this great organization’s efforts in promoting solutions for the needs of individuals with autism and their families.”

Ice Cube’s design is available on a variety of products for men and women, starting at $24.99, available at Represent.com/IceCube.

The campaign will be open until Tuesday, March 7, with proceeds from the campaign supporting Autism Speaks. This year, the ninth annual World Autism Awareness Day will take place on April 2, during which supporters and organizations around the world will come together to raise awareness and show support for those affected by this disorder.

About Represent

Founded in 2014, Represent connects celebrity influencers directly with their fans and communities through unique limited edition apparel campaigns that raise funding for select causes and charities. Past Represent campaigns have included athletes, musicians, and entertainment influencers such as Arnold Schwarzenegger, Kobe Bryant, Will Ferrell, Ronda Rousey, Jennifer Lopez and many more. Keep Reading

ADA Commends Environmental Protection Agency for Adhering to High Standards of Science in Rejecting Anti-Fluoridation Group’s Request

in BREAKING NEWS/food/food safety/Health/water by
Reading Time: 2 minutes

WASHINGTON, Feb. 27, 2017 /360WiseNews/ — The American Dental Association (ADA) commends the Environmental Protection Agency (EPA) for its scientifically sound decision today to deny a request to ban community water fluoridation.  Hundreds of communities across the country optimally fluoridate their water supplies, providing an estimated 211 million people with increased protection from dental disease.

In November of last year, a group opposed to community water fluoridation petitioned the EPA with a request that the agency ban the addition of fluoridating chemicals to drinking water. The petitioners claimed that the level of fluoride used by communities across the nation negatively affects IQs.

EPA scientists denied the petition, noting in their official justification that, “the petition has not set forth a scientifically defensible basis to conclude that any persons have suffered neurotoxic harm as a result of exposure to fluoride in the U.S. through the purposeful addition of fluoridation chemicals to drinking water or otherwise from fluoride exposure in the U.S.”

The EPA justification, published Feb. 27 in the Federal Register, noted principles associated with sound science: “When an association is suggested between an exposure and a disease outcome, the studies need to be assessed to determine whether the effect is truly because of exposure or if alternate explanations are possible. The way to do that is to adjust for potential confounders, such as diet, behavior, and socioeconomic status […]”

“It is always heartening when our government comes down on the side of sound science,” said ADA President Gary Roberts. “Public health policy recommending community water fluoridation results from years of scientifically rigorous analysis of the amount of fluoride people receive from all sources. Keep Reading

Activia Spotlights the Strength of Women With New ‘It Starts Inside’ Campaign

in BREAKING NEWS/Health/Press Release/Women by
Reading Time: 3 minutes

Leading Probiotic Yogurt Calls on Women to Unleash their Best Potential

WHITE PLAINS, N.Y., Feb. 21, 2017 /360WiseNews/ — Activia today announces “Don’t Tell Me I Can’t,” a powerful video that is part of the brand’s national rebranding campaign: ‘It Starts Inside.’ With a fresh new look and brand vision, Activia’s new campaign is built on the insight that while women are powerful and comfortable overcoming obstacles, they might not realize that they can be their own harshest critic. Activia hopes that this film will spark a conversation and encourage women to overcome their inner hurdles – and inner critic – to achieve their full potential.

As the brand’s newest creative, “Don’t Tell Me I Can’t” features candid interviews with women who face the realization that self-doubt is often the biggest barrier that can hold them back. The spot offers a look at women’s determination when told that they can’t achieve something by others, with confident assertions that they would “laugh in their face” and “prove them wrong.” When asked if they’ve ever told themselves that they can’t do something, these same women recall moments of self-doubt, saying that they’ve had to face their inner critic to accomplish their goals.

According to research conducted by Activia, 80% of women agree that they are their own worst critic*. Activia wants to inspire women to rise above their inner critic, and for each woman to recognize that she is filled with the potential to achieve whatever she wants – no matter how big or small. Activia believes this starts inside.

“The ‘It Starts Inside’ campaign embraces a new brand purpose and vision to encourage every woman to overcome her inner hurdles and unlock the potential to be her best self,” said Carolina Cespedes, Senior Brand Director for Activia at The Dannon Company. “We’re marrying the benefits of our yogurt with a new rallying cry – It Starts Inside – to offer a product and platform to help women feel good inside and out.” Keep Reading

1 2 3 4
Go to Top